Cargando…
Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer
BACKGROUND: The dilemma of pancreatic cancer treatment has become a global challenge. For this reason, effective, feasible, and new medical methods are currently much-needed. Betulinic acid (BA) has been valued as a potential therapy for pancreatic cancer. However, the mechanism by which BA exerts a...
Autores principales: | LI, XIN, JIANG, WENKAI, LI, WANCHENG, DONG, SHI, DU, YAN, ZHANG, HUI, ZHOU, WENCE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319593/ https://www.ncbi.nlm.nih.gov/pubmed/37415745 http://dx.doi.org/10.32604/or.2023.026959 |
Ejemplares similares
-
STAT3 Inhibitors: A Novel Insight for Anticancer Therapy of Pancreatic Cancer
por: Li, Xin, et al.
Publicado: (2022) -
Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023) -
Current understanding of ferroptosis in the progression and treatment of pancreatic cancer
por: Dong, Shi, et al.
Publicado: (2021) -
miR‐365 secreted from M2 Macrophage‐derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis
por: Li, Xin, et al.
Publicado: (2021) -
Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer
por: Li, Xin, et al.
Publicado: (2023)